Identification of metastasis‐related microRNAs in hepatocellular carcinoma

By A. Budhu, H. Jia, M. Forgues, Chang Liu, D. Goldstein, A. Lam, Krista A. Zanetti, Q. Ye, L. Qin, Carlo Maria Croce and 2 more. Hepatology, 2008

738 citations recorded by the source corpus.

Subfields: Cancer Research, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/204c7ec0f5d35e45393580b009a35423da1db7f3

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cancer Research

In Molecular Biology

Citations in the corpus

Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma. (2011, background): “…et al., 2007, 2008, 2009; Braconi and Patel, 2008; Ji et al., 2009a, 2009b; Ladeiro et al., 2008; Varnholt et al., 2008; Wang et al., 2008, 2009a; Wong et al., 2008; Murakami et al., 2006; Kutay et al., 2006; Budhu et al., 2008; Ura et al., 2009; Coulouarn et al., 2009; Xiong et al., 2010).”
Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties (2009, neutral): “…of miR-122 has been found to be repressed in HCC (Kutay et al., 2006; Murakami et al., 2006; Gramantieri et al., 2007; Braconi and Patel, 2008; Budhu et al., 2008; Girard et al., 2008; Ladeiro et al., Received 25 January 2009; revised 8 June 2009; accepted 18 June 2009; published online 20…”
METTL14 suppresses the metastatic potential of hepatocellular carcinoma by modulating N6‐methyladenosine‐dependent primary MicroRNA processing (2017, background): “MiR126 was also identified as a metastasis suppressor in human breast cancer and hepatocellular cancer.((25-28)) We then examined the expression of miR126 and pri-miR126 in METTL14-knockdown or METTL14-overexpressing cell lines.”
A microRNA DNA methylation signature for human cancer metastasis (2008, result): “Our data also corroborate the findings of recent studies showing that miR-34 activation recapitulates tumor suppressor events associated with p53 activity (28, 29) and that the downregulation of miR-148a, miR-9-2, and miR-34 is part of a unique 20-miRNA metastasis signature in liver tumors (30).”
MicroRNAs — the micro steering wheel of tumour metastases (2009, background): “By analysing a large cohort of HCC patients, Budhu and colleagues from Wang's group identified a unique 20-miRNA metastasis signature that could predict primary HCC tumours with venous metastases from metastasis-free tumour”
Reprogramming of miRNA networks in cancer and leukemia. (2010, neutral): “GSE8126 and GSE7055 (Ambs et al. 2008), GSE17155 (Fassan et al. 2009), GSE3467 (He et al. 2005), GSE7828 (Schetter et al. 2008), GSE6857 (Budhu et al. 2008), GSE16654 (Chin et al. 2009), and GSE14936 (Seike et al. 2009), and at ArrayExpress (www.ebi.ac.uk/microarray-as/ae) under accession nos.”